Follicular helper T cells: Implications in neoplastic hematopathology

Seminars in Diagnostic Pathology

Volumn 28, Issue 3, 2011, Pages 202-213

  Gaulard, Philippe ^a,b,c   de Leval, Laurence ^d  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c INSERM U955   (France)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Angioimmunoblastic T cell lymphoma (AITL); Follicular lymphoma; Follicular T helper cells (TFH); Nodular lymphocyte predominant Hodgkin lymphoma; TFH derived lymphomas

Indexed keywords

CXCL13 CHEMOKINE; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN BCL 6;

ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ANTIBODY RESPONSE; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL SURVIVAL; CLINICAL FEATURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FOLLICULAR LYMPHOMA; FOLLICULAR T HELPER CELL; HELPER CELL; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOCYTE HOMING; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; T CELL LYMPHOMA; TUMOR MICROENVIRONMENT;

EID: 79960119717     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2011.03.003     Document Type: Article

References (83)

1. Vinuesa C.G., Tangye S.G., Moser B., et al. Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol 2005, 5:853-865.
2. Fazilleau N., Mark L., McHeyzer-Williams L.J., et al. Follicular helper T cells: Lineage and location. Immunity 2009, 30:324-335.
3. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011, 29:621-623.
4. Chtanova T., Tangye S.G., Newton R., et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 2004, 173:68-78.
5. Huang Y., Moreau A., Dupuis J., et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol 2009, 33:682-690.
6. Rodríguez-Pinilla S.M., Roncador G., Rodríguez-Peralto J.L., et al. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 2009, 33:81-90.
7. McHeyzer-Williams L.J., Pelletier N., Mark L., et al. Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol 2009, 21:266-273.
8. Rolf J., Fairfax K., Turner M. Signaling pathways in T follicular helper cells. J Immunol 2010, 184:6563-6568.
9. Nurieva R.I., Chung Y., Martinez G.J., et al. Bcl6 mediates the development of T follicular helper cells. Science 2009, 325:1001-1005.
10. Yu D., Vinuesa C.G. The elusive identity of T follicular helper cells. Trends Immunol 2010, 31:377-383.
11. Dorfman D.M., Brown J.A., Shahsafaei A., et al. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2006, 30:802-810.
12. Krenacs L., Schaerli P., Kis G., et al. Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells. Blood 2006, 108:1110-1111.
13. Roncador G., García Verdes-Montenegro J.F., Tedoldi S., et al. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 2007, 92:1059-1066.
14. Dupuis J., Boye K., Martin N., et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): A new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 2006, 30:490-494.
15. Yu H., Shahsafaei A., Dorfman D.M. Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma. Am J Clin Pathol 2009, 131:33-41.
16. Marafioti T., Paterson J.C., Ballabio E., et al. The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. Haematologica 2010, 95:432-439.
17. Xerri L., Chetaille B., Serriari N., et al. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum Pathol 2008, 39:1050-1058.
18. Ree H.J., Kadin M.E., Kikuchi M., et al. Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: Heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. Hum Pathol 1999, 30:403-411.
19. Yuan C.M., Vergilio J.A., Zhao X.F., et al. CD10 and BCL6 expression in the diagnosis of angioimmunoblastic T-cell lymphoma: Utility of detecting CD10+ T cells by flow cytometry. Hum Pathol 2005, 36:784-791.
20. Natkunam Y., Tedoldi S., Paterson J.C., et al. Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia. Am J Clin Pathol 2009, 132:361-371.
21. Rasheed A.U., Rahn H.P., Sallusto F., et al. Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression. Eur J Immunol 2006, 36:1892-1903.
22. Dorfman D.M., Shahsafaei A. CD200 (OX-2 membrane glycoprotein) is expressed by follicular T helper cells and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2011, 35:76-83.
23. Attygalle A., Al-Jehani R., Diss T.C., et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002, 99:627-633.
24. Attygalle A.D., Kyriakou C., Dupuis J., et al. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: Clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 2007, 31:1077-1088.
25. Attygalle A.D., Diss T.C., Munson P., et al. CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2004, 28:54-61.
26. Karube K., Aoki R., Nomura Y., et al. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases. Pathol Int 2008, 58:89-97.
27. Cook J.R., Craig F.E., Swerdlow S.H. Benign CD10-positive T cells in reactive lymphoid proliferations and B-cell lymphomas. Mod Pathol 2003, 16:879-885.
28. Stacchini A., Demurtas A., Aliberti S., et al. The usefulness of flow cytometric CD10 detection in the differential diagnosis of peripheral T-cell lymphomas. Am J Clin Pathol 2007, 128:854-864.
29. Rodriguez-Justo M., Attygalle A.D., Munson P., et al. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: A neoplasia with origin in the outer zone of the germinal centre?. Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers. Mod Pathol 2009, 22:753-761.
30. Morita R., Schmitt N., Bentebibel S.E., et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011, 34:108-121.
31. Marinova E., Han S., Zheng B. Germinal center helper T cells are dual functional regulatory cells with suppressive activity to conventional CD4+ T cells. J Immunol 2007, 178:5010-5017.
32. de Leval L., Gisselbrecht C., Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 2010, 148:673-689.
33. de Leval L., Rickman D.S., Thielen C., et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007, 109:4952-4963.
34. Piccaluga P.P., Agostinelli C., Califano A., et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 2007, 67:10703-10710.
35. Iqbal J., Weisenburger D.D., Greiner T.C., et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010, 115:1026-1036.
36. Armitage J., Vose J., Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes. J Clin Oncol 2008, 26:4124-4130.
37. Rüdiger T., Weisenburger D.D., Anderson J.R., et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): Results from the non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002, 13:140-149.
38. Mourad N., Mounier N., Brière J., et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 2008, 111:4463-4470.
39. Ree H.J., Kadin M.E., Kikuchi M., et al. Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol 1998, 22:643-655.
40. Patsouris E., Noël H., Lennert K. Angioimmunoblastic lymphadenopathy-Type of T-cell lymphoma with a high content of epithelioid cells. Histopathology and comparison with lymphoepithelioid cell lymphoma. Am J Surg Pathol 1989, 13:262-275.
41. Lome-Maldonado C., Canioni D., Hermine O., et al. Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subtype of ailed-TL?. Leukemia 2002, 16:2134-2141.
42. Brüggemann M., White H., Gaulard P., et al. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies report of the Biomed-2 Concerted Action BHM4 CT98-3936. Leukemia 2007, 21:215-221.
43. Bräuninger A., Spieker T., Willenbrock K., et al. Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) Epstein-Barr virus-infected B cells in angioimmunoblastic T-cell lymphoma. J Exp Med 2001, 194:927-940.
44. Zettl A., Lee S.S., Rüdiger T., et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 2002, 117:368-379.
45. Willenbrock K., Bräuninger A., Hansmann M.L. Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. Br J Haematol 2007, 138:733-739.
46. Willenbrock K., Roers A., Seidl C., et al. Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor-beta gene rearrangements. Am J Pathol 2001, 158:1851-1857.
47. Lee S.S., Rüdiger T., Odenwald T., et al. Angioimmunoblastic T cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4. Int J Cancer 2003, 103:12-20.
48. Attygalle A.D., Chuang S.S., Diss T.C., et al. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics. Histopathology 2007, 50:498-508.
49. Grogg K.L., Attygalle A.D., Macon W.R., et al. Angioimmunoblastic T-cell lymphoma: A neoplasm of germinal-center T-helper cells?. Blood 2005, 106:1501-1502.
50. Baseggio L., Berger F., Morel D., et al. Identification of circulating CD10 positive T cells in angioimmunoblastic T-cell lymphoma. Leukemia 2006, 20:296-303.
51. Ortonne N., Dupuis J., Plonquet A., et al. Characterization of CXCL13+ neoplastic T cells in cutaneous lesions of angioimmunoblastic T-cell lymphoma (AITL). Am J Surg Pathol 2007, 31:1068-1076.
52. Zhao W.L., Mourah S., Mounier N., et al. Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Lab Invest 2004, 84:1512-1519.
53. Konstantinou K., Yamamoto K., Ishibashi F., et al. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma. Br J Haematol 2009, 144:696-704.
54. Tripodo C., Gri G., Piccaluga P.P., et al. Mast cells and th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma. Am J Pathol 2010, 177:792-802.
55. Niino D., Komohara Y., Murayama T., et al. Ratio of M2 macrophage expression is closely associated with poor prognosis for angioimmunoblastic T-cell lymphoma (AITL). Pathol Int 2010, 60:278-283.
56. Bruneau J., Canioni D., Renand A., et al. Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. Am J Pathol 2010, 177:570-574.
57. de Leval L., Bisig B., Thielen C., et al. Molecular classification of T-cell lymphomas. Crit Rev Oncol/Hematol 2009, 72:125-143.
58. Dogan A., Attygalle A.D., Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol 2003, 121:681-691.
59. Leich E., Haralambieva E., Zettl A., et al. Tissue microarray-based screening for chromosomal breakpoints affecting the T-cell receptor gene loci in mature T-cell lymphomas. J Pathol 2007, 213:99-105.
60. de Leval L., Savilo E., Longtine J., et al. Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype. Am J Surg Pathol 2001, 25:395-400.
61. Rüdiger T., Ichinohasama R., Ott M.M., et al. Peripheral T-cell lymphoma with distinct perifollicular growth pattern: A distinct subtype of T-cell lymphoma?. Am J Surg Pathol 2000, 24:117-122.
62. Ikonomou I.M., Tierens A., Troen G., et al. Peripheral T-cell lymphoma with involvement of the expanded mantle zone. Virchows Arch 2006, 449:78-87.
63. Bacon C.M., Paterson J.C., Liu H., et al. Peripheral T-cell lymphoma with a follicular growth pattern: Derivation from follicular helper T cells and relationship to angioimmunoblastic T-cell lymphoma. Br J Haematol 2008, 143:439-441.
64. Streubel B., Vinatzer U., Willheim M., et al. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006, 20:313-318.
65. Rigby S., Huang Y., Streubel B., et al. The lymphoma-associated fusion tyrosine kinase ITK-SYK requires pleckstrin homology domain-mediated membrane localization for activation and cellular transformation. J Biol Chem 2009, 284:26871-26881.
66. Pechloff K., Holch J., Ferch U., et al. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J Exp Med 2010, 207:1031-1044.
67. Dierks C., Adrian F., Fisch P., et al. The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease. Cancer Res 2010, 70:6193-6204.
68. Feldman A.L., Sun D.X., Law M.E., et al. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia 2008, 22:1139-1143.
69. Wilcox R.A., Sun D.X., Novak A., et al. Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines. Leukemia 2010, 24:229-232.
70. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, IARC Publishing Group, Lyon. S. Swerdlow (Ed.).
71. Le Tourneau A., Audouin J., Molina T., et al. Primary cutaneous follicular variant of peripheral T-cell lymphoma NOS. A report of two cases. Histopathology 2010, 56:548-551.
72. Muenst S., Hoeller S., Dirnhofer S., et al. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival. Hum Pathol 2009, 40:1715-1722.
73. Nguyen P.L., Ferry J.A., Harris N.L. Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's disease: A comparative immunohistochemical study. Am J Surg Pathol 1999, 23:27-33.
74. Kraus M.D., Haley J. Lymphocyte predominance Hodgkin's disease: The use of bcl-6 and CD57 in diagnosis and differential diagnosis. Am J Surg Pathol 2000, 24:1068-1078.
75. Nam-Cha S.H., Roncador G., Sanchez-Verde L., et al. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol 2008, 32:1252-1257.
76. Churchill H.R., Roncador G., Warnke R.A., et al. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: Comparison with CD57 and lymphomas in the differential diagnosis. Hum Pathol 2010, 41:1726-1734.
77. Quintanilla-Martinez L., de Jong D., de Mascarel A., et al. Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. J Hematop 2009, 2:211-236.
78. Nam-Cha S.H., Montes-Moreno S., Salcedo M.T., et al. Lymphocyte-rich classical Hodgkin's lymphoma: Distinctive tumor and microenvironment markers. Mod Pathol 2009, 22:1006-1015.
79. Dave S.S., Wright G., Tan B., et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004, 351:2159-2169.
80. Carreras J., Lopez-Guillermo A., Roncador G., et al. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol 2009, 27:1470-1476.
81. Muenst S., Hoeller S., Willi N., et al. Diagnostic and prognostic utility of PD-1 in B cell lymphomas. Dis Markers 2010, 29:47-53.
82. Richendollar B.G., Pohlman B., Elson P., et al. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma. Hum Pathol 2011, 42:552-557.
83. Pangault C., Amé-Thomas P., Ruminy P., et al. Follicular lymphoma cell niche: Identification of a preeminent IL-4-dependent T(FH)-B cell axis. Leukemia 2010, 24:2080-2089.